Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Impact of Selected Signaling Proteins on SNAIL 1 and SNAIL 2 Expression in Ovarian Cancer Cell Lines in Relation to Cells' Cisplatin Resistance and EMT Markers Level
Michal Kielbik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
DNA hypermethylation associated with upregulated gene expression in prostate cancer demonstrates the diversity of epigenetic regulation
Ieva Rauluseviciute et al.
BMC MEDICAL GENOMICS (2020)
Cisplatin resistance in gastric cancer cells is involved with GPR30-mediated epithelial-mesenchymal transition
Xiaofeng Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells
Zdravka Medarova et al.
SCIENTIFIC REPORTS (2020)
DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer
Eva Galle et al.
CLINICAL EPIGENETICS (2020)
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Karol Bukowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance
Milad Ashrafizadeh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Role of DNA Methylation in the Resistance to Therapy in Solid Tumors
Susana Romero-Garcia et al.
FRONTIERS IN ONCOLOGY (2020)
Histone methyltransferase and drug resistance in cancers
Cheng Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis
Kritika Saxena et al.
TRANSLATIONAL ONCOLOGY (2020)
Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway
Mingjing Shen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Cisplatin: The first metal based anticancer drug
Sumit Ghosh
BIOORGANIC CHEMISTRY (2019)
Ovarian Cancer Stemness: Biological and Clinical Implications for Metastasis and Chemotherapy Resistance
Takeshi Motohara et al.
CANCERS (2019)
Roles of the Phosphorylation of Transcriptional Factors in Epithelial-Mesenchymal Transition
Rong Xu et al.
JOURNAL OF ONCOLOGY (2019)
The multi-factorial nature of clinical multidrug resistance in cancer
Yehuda G. Assaraf et al.
DRUG RESISTANCE UPDATES (2019)
TWIST2: A new candidate tumor suppressor in prostate cancer
Chengxiao Zhao et al.
PROSTATE (2019)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration
Nicole M. Aiello et al.
DEVELOPMENTAL CELL (2018)
Functions of EpCAM in physiological processes and diseases (Review)
Li Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Snail knockdown reverses stemness and inhibits tumour growth in ovarian cancer
N. Hojo et al.
SCIENTIFIC REPORTS (2018)
FOXC2 promotes epithelial-mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells
Yuwen He et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
DNA repair pathways and cisplatin resistance: an intimate relationship
Clarissa Ribeiro Reily Rocha et al.
CLINICS (2018)
Role of Epithelial-Mesenchymal Transition in Tumor Progression
N. A. Gloushankova et al.
BIOCHEMISTRY-MOSCOW (2018)
PD98059 impairs the cisplatin-resistance of ovarian cancer cells by suppressing ERK pathway and epithelial mesenchymal transition process
Li Hou et al.
CANCER BIOMARKERS (2018)
Early events in the assembly of E-cadherin adhesions
Kabir H. Biswas et al.
EXPERIMENTAL CELL RESEARCH (2017)
MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line
Yankun Liu et al.
ONCOLOGY LETTERS (2017)
Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines
Valentina Fustaino et al.
ONCOTARGET (2017)
Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines
Radoslaw Januchowski et al.
ONCOTARGET (2017)
DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian Cancer
Riikka J. Lund et al.
SCIENTIFIC REPORTS (2017)
Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells
Maura Sonego et al.
SCIENTIFIC REPORTS (2017)
A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells
Xi Han et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells
Shuo Li et al.
CELL CYCLE (2017)
Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance
Bernadette M. Boac et al.
GYNECOLOGIC ONCOLOGY (2016)
Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications
Silvia Juliana Serrano-Gomez et al.
MOLECULAR CANCER (2016)
Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines
Radoslaw Januchowski et al.
JOURNAL OF OVARIAN RESEARCH (2016)
Gene expression profiling of ovarian carcinomas and prognostic analysis of outcome
Sheng-Yun Cai et al.
JOURNAL OF OVARIAN RESEARCH (2015)
Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer
Q. H. Miow et al.
ONCOGENE (2015)
TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer
Jose A. Galvan et al.
ONCOTARGET (2015)
EMT and tumor metastasis
Sarah Heerboth et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2015)
Comparative Study of the Sensitivities of Cancer Cells to Doxorubicin, and Relationships between the Effect of the Drug-Efflux Pump P-gp
Golam Kibria et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2014)
Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line
Radoslaw Januchowski et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
A Comprehensive DNA Methylation Profile of Epithelial-to-Mesenchymal Transition
F. Javier Carmona et al.
CANCER RESEARCH (2014)
Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFR
Shengxiang Ren et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells
Pei Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer
Hannah Woopen et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2014)
Oncogenic roles of EMT-inducing transcription factors
Alain Puisieux et al.
NATURE CELL BIOLOGY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Twist2 contributes to cisplatin-resistance of ovarian cancer through the AKT/GSK-3β signaling pathway
Tian Wang et al.
ONCOLOGY LETTERS (2014)
DNA methylation is associated with transcription of Snail and Slug genes
Ying Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
EpCAM: Structure and function in health and disease
Ulrike Schnell et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)
An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
Lauren Averett Byers et al.
CLINICAL CANCER RESEARCH (2013)
DNA Methylation and Its Basic Function
Lisa D. Moore et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Acquisition of paclitaxel resistance via PI3K-dependent epithelial-mesenchymal transition in A2780 human ovarian cancer cells
Fangfang Du et al.
ONCOLOGY REPORTS (2013)
The Role of Nuclear β-Catenin Accumulation in the Twist2-Induced Ovarian Cancer EMT
Yubin Mao et al.
PLOS ONE (2013)
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
R. Y-J Huang et al.
CELL DEATH & DISEASE (2013)
MDR Gene Expression Analysis of Six Drug-Resistant Ovarian Cancer Cell Lines
Radoslaw Januchowski et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
Optimal first-line treatment in ovarian cancer
F. A. Raja et al.
ANNALS OF ONCOLOGY (2012)
Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells
Weijia Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin)
Cristina Oliveras-Ferraros et al.
CELL CYCLE (2012)
Targeting Pathways Contributing to Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer
Ruby Yun-Ju Huang et al.
CURRENT DRUG TARGETS (2012)
Cancer epigenomics: beyond genomics
Juan Sandoval et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
C. Zeller et al.
ONCOGENE (2012)
Target cell movement in tumor and cardiovascular diseases based on the epithelial-mesenchymal transition concept
Kian-Ngiap Chua et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern
Ozlem Darcansoy Iseri et al.
BIOMEDICINE & PHARMACOTHERAPY (2011)
Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancer
B. T. F. van der Gun et al.
BRITISH JOURNAL OF CANCER (2011)
Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition
Oliver G. McDonald et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
Ana-Maria Florea et al.
Cancers (2011)
Identification of Hypermethylated Genes Associated with Cisplatin Resistance in Human Cancers
Xiaofei Chang et al.
CANCER RESEARCH (2010)
High-Definition DNA Methylation Profiles from Breast and Ovarian Carcinoma Cell Lines with Differing Doxorubicin Resistance
Michael Boettcher et al.
PLOS ONE (2010)
Persistent downregulation of the pancarcinoma-associated epithelial cell adhesion molecule via active intranuclear methylation
Bernardina T. F. van der Gun et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel
Lanlan Shen et al.
CANCER RESEARCH (2007)
Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: An exception to the norm
Nuzhat Ahmed et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
MethyIScreen: DNA methylation density monitoring using quantitative PCR
H. Holemon et al.
BIOTECHNIQUES (2007)
Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue
Gilbert Spizzo et al.
CANCER LETTERS (2007)
Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets
J. M. Ordway et al.
CARCINOGENESIS (2006)
Impaired cisplatin influx in an A2780 mutant cell line - Evidence for a putative, cis-configuration-specific, platinum influx transporter
Jozien Helleman et al.
CANCER BIOLOGY & THERAPY (2006)
DNA damage-induced cell death by apoptosis
Wynand P. Roos et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients
RL Yauch et al.
CLINICAL CANCER RESEARCH (2005)
Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level
NK Kurrey et al.
GYNECOLOGIC ONCOLOGY (2005)
The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions:: a comparison with Snail and E47 repressors
V Bolós et al.
JOURNAL OF CELL SCIENCE (2003)
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future
M Esteller
ONCOGENE (2002)
The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
E Batlle et al.
NATURE CELL BIOLOGY (2000)
Share Paper
